Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
OcugenOCGN |
$78,000 |
 |
AmarinAMRN |
$520,000 |
 |
Gilead SciencesGILD |
-$2B |
 |
Anavex Life SciencesAVXL |
-$6.3M |
 |
AmgenAMGN |
-$109M |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| Alphabet Inc. | Aug 1, 2025 | Buy | 1,500,000 | $3.3 | $5M |
| NELSEN ROBERT | Aug 1, 2025 | Buy | 3,030,300 | $3.3 | $10M |
| ARCH Venture Fund XII, L.P. | Aug 1, 2025 | Buy | 3,030,300 | $3.3 | $10M |
| CRANDELL KEITH | Aug 1, 2025 | Buy | 3,030,300 | $3.3 | $10M |
| Liu David R. | Jun 30, 2025 | Buy | 21,000 | $2.5157 | $53,000 |
| Liu David R. | Jun 23, 2025 | Buy | 21,000 | $2.162 | $45,000 |
| Liu David R. | Jun 16, 2025 | Buy | 21,000 | $1.4855 | $31,000 |
| Liu David R. | Jun 11, 2025 | Buy | 21,000 | $1.5995 | $34,000 |
| LEE ANN L. | May 21, 2025 | Buy | 100,000 | $1.13 | $110,000 |
| Reine Allan | May 21, 2025 | Buy | 125,000 | $1.1772 | $150,000 |
| Brudnick Richard | May 20, 2025 | Buy | 20,000 | $1.1895 | $24,000 |
FAQ - Insider Transactions
The most recent insider transaction for Prime Medicine was conducted by Alphabet Inc., who sold 1,500,000 shares on August 1, 2025 at a price of $3.30 per share.
CRANDELL KEITH has bought the most PRME stock in the last 2 years, with a total value of $10M.
According to our estimates, the total value of insider transactions for Prime Medicine in the last 2 years is positive, amounting to $35M. This indicates that insiders have predominantly bought shares, showcasing their confidence in the company's future prospects.
Over the last 2 years, insider transactions for Prime Medicine have predominantly involved purchasing shares, indicating a strong confidence among insiders in the company's future prospects. This trend of more purchases than sales could be a positive signal to potential investors about the insiders' view on the company's valuation and growth potential.
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
